Cable Hill Partners’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-4,729
| Closed | -$22K | – | 808 |
|
|
2019
Q1 | $22K | Hold |
4,729
| – | – | 0.01% | 364 |
|
|
2018
Q4 | $20K | Buy |
4,729
+450
| +11% | +$1.9K | 0.01% | 350 |
|
|
2018
Q3 | $26K | Sell |
4,279
-50
| -1% | -$304 | 0.01% | 271 |
|
|
2018
Q2 | $35K | Hold |
4,329
| – | – | 0.01% | 240 |
|
|
2018
Q1 | $31K | Buy |
4,329
+1,451
| +50% | +$10.4K | 0.01% | 267 |
|
|
2017
Q4 | $18K | Buy |
2,878
+26
| +0.9% | +$163 | 0.01% | 438 |
|
|
2017
Q3 | $21K | Buy |
2,852
+1,979
| +227% | +$14.6K | 0.01% | 397 |
|
|
2017
Q2 | $6K | Sell |
873
-3
| -0.3% | -$21 | ﹤0.01% | 532 |
|
|
2017
Q1 | $8K | Sell |
876
-42
| -5% | -$384 | ﹤0.01% | 462 |
|
|
2016
Q4 | $8K | Buy |
+918
| New | +$8K | ﹤0.01% | 464 |
|